Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-13-003511
Filing Date
2013-05-10
Accepted
2013-05-09 18:24:09
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q imuc-10q_20130331.htm 10-Q 722156
2 EX-10.1 imuc-ex10_20130331413.htm EX-10 68115
3 EX-31.1 imuc-ex31_20130331239.htm EX-31 16708
4 EX-31.2 imuc-ex31_20130331240.htm EX-31 16710
5 EX-32.1 imuc-ex32_20130331242.htm EX-32 7729
6 EX-32.2 imuc-ex32_20130331241.htm EX-32 7755
  Complete submission text file 0000950123-13-003511.txt   6287495

Data Files

Seq Description Document Type Size
7 imuc-20130331.xml EX-101.INS 861277
8 imuc-20130331.xsd EX-101.SCH 62779
9 imuc-20130331_cal.xml EX-101.CAL 31345
10 imuc-20130331_def.xml EX-101.DEF 260738
11 imuc-20130331_lab.xml EX-101.LAB 390193
12 imuc-20130331_pre.xml EX-101.PRE 306461
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35560 | Film No.: 13830494
SIC: 2834 Pharmaceutical Preparations